A SPECIFIC, SENSITIVE RADIOIMMUNOASSAY FOR PLATELET-ACTIVATING FACTOR (PAF)

被引：28
作者：
SMAL, MA
BALDO, BA
MCCASKILL, A
机构：
[1] ROYAL N SHORE HOSP,KOLLING INST MED RES,ST LEONARDS,NSW 2065,AUSTRALIA
[2] SILENUS LABS PTY LTD,HAWTHORN,VIC 3122,AUSTRALIA
[3] UNIV SYDNEY,DEPT MED,SYDNEY,NSW 2006,AUSTRALIA
来源：
JOURNAL OF IMMUNOLOGICAL METHODS | 1990年 / 128卷 / 02期
关键词：
Anti-platelet-activating factor; Platelet-activating factor; Platelet-activating factor radioimmunoassay; Quantitation of platelet-activating factor;
D O I：
10.1016/0022-1759(90)90209-E
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
A specific radioimmunoassay (RIA) has been developed for platelet-activating factor (PAF) and shown to be sensitive over the range 10-1000 pg (0.02-2 pmol). The anti-PAF antibodies showed specificity for the acetyl group at the C2 position of the PAF molecule and exhibited no significant cross-reactivity with lyso-PAF or the naturally occurring lipids including lecithin and lysolecithin. The sensitivity of the RIA was at least as good as the platelet-based assays for PAF but the RIA was simpler to perform, had a higher capacity and did not have the drawback of the inherent variability associated with the bioassays. © 1990.
引用
收藏
页码：183 / 188
页数：6
相关论文
共 50 条
  • [21] Protein tyrosine phosphorylation in equine platelets: The effect of stimulation by thrombin and platelet-activating factor (PAF)
    Dillon, AMR
    Heath, MF
    EQUINE VETERINARY JOURNAL, 1995, 27 (06) : 448 - 458
  • [22] Mammalian platelet-activating factor acetylhydrolases
    Stafforini, DM
    Prescott, SM
    Zimmerman, GA
    McIntyre, TM
    BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1996, 1301 (03): : 161 - 173
  • [23] Platelet-activating factor and human meningiomas
    Denizot, Y.
    De Armas, R.
    Caire, F.
    Pommepuy, I.
    Truffinet, V.
    Labrousse, F.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2006, 32 (06) : 674 - 678
  • [24] B-cell-activating factor (BAFF) and platelet-activating factor (PAF) in pregnancies complicated by maternal obesity and diabetes: a preliminary study
    Neri, Caterina
    Ciliberti, Alessandra
    Dessi, Davide Archelao
    Airoldi, Chiara
    Basello, Katia
    Costanzi, Andrea
    Familiari, Alessandra
    Tersigni, Chiara
    Cappelletti, Mattia
    Speciani, Attilio Francesco
    Lanzone, Antonio
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2023, 36 (02)
  • [25] The role of tumour necrosis factor-α (TNF-α) and platelet-activating factor (PAF) interaction on murine candidosis
    Kalkanci, A
    Kustimur, S
    Timlioglu, Ö
    Uluoglu, C
    MYCOSES, 2002, 45 (3-4) : 79 - 83
  • [26] Modifications of plasma platelet-activating factor (PAF)-acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection
    Caini, P.
    Guerra, C. Tosti
    Giannini, C.
    Giannelli, F.
    Gragnani, L.
    Petrarca, A.
    Solazzo, V.
    Monti, M.
    Laffi, G.
    Zignego, A. L.
    JOURNAL OF VIRAL HEPATITIS, 2007, 14 (01) : 22 - 28
  • [27] Sensitive densitometry for the determination of platelet-activating factor and other phospholipids in human tears
    Ohyama, T
    Matsubara, C
    Takamura, K
    ANALYST, 1996, 121 (12) : 1943 - 1947
  • [28] MEASUREMENT OF HUMAN EMBRYO-DERIVED PLATELET-ACTIVATING FACTOR (PAF) USING A QUANTITATIVE BIOASSAY OF PLATELET-AGGREGATION
    COLLIER, M
    ONEILL, C
    AMMIT, AJ
    SAUNDERS, DM
    HUMAN REPRODUCTION, 1990, 5 (03) : 323 - 328
  • [29] Platelet-activating factor (PAF) induces wheal and flare skin reactions independent of mast cell degranulation
    Krause, K.
    Gimenez-Arnau, A.
    Martinez-Escala, E.
    Farre-Albadalejo, M.
    Abajian, M.
    Church, M. K.
    Maurer, M.
    ALLERGY, 2013, 68 (02) : 256 - 258
  • [30] Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism
    Huang, YH
    Schäfer-Elinder, L
    Wu, R
    Claesson, HE
    Frostegård, J
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1999, 116 (02) : 326 - 331
12345